Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity

Citation

Lidbury, BA, Kita, B, Richardson, A et al 2019, 'Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity', Diagnostics, vol. 9, no. 79, pp. 1-21.

Year

2019

Field of Research

  • Health Information Systems (Incl. Surveillance)

Updated:  23 January 2020 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers